Are There Treatment Options Targeted at BRCA-Related Cancers?
Yes, there are targeted treatments for cancers caused by BRCA mutations. PARP inhibitors are a class of drugs that have shown effectiveness in treating BRCA-mutated cancers. These inhibitors work by blocking an enzyme used by cells to repair damaged DNA, which is particularly effective in cancer cells with BRCA mutations that already have compromised DNA repair mechanisms.